- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
TMG and Chi Systems build Imaging Integration Program
TMG and Chi Systems build Imaging Integration ProgramThe PACS and image management consulting program offered as a joint venture between Technology Marketing Group of Des Plaines, IL, and Chi Systems of Ann Arbor, MI, has added three new
TMG and Chi Systems build Imaging Integration Program
The PACS and image management consulting program offered as a joint venture between Technology Marketing Group of Des Plaines, IL, and Chi Systems of Ann Arbor, MI, has added three new members. Joining the firms' Imaging Integration Program are Samuel Dwyer, Philip Drew, and Herman Oosterwijk.
Dwyer is a consultant and a professor of radiology at the University of Virginia Health Sciences Center, and Drew is president of the Concord, MA-based Concord Consulting Group and past president of the Society for Computer Applications in Radiology. Oosterwijk has worked extensively in the PACS industry with Philips and Kodak, according to TMG.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
